GeneDx

A diagnosis can change everything: the care plan, the possibilities, and the hope. Because Diagnosis is Power. The power to understand, act, and move forward with clarity. 🎥 This is our anthem. A rally cry for what’s possible when answers replace uncertainty. Behind every test is a person. And behind every result is a path forward. Watch now. #DiagnosisIsPower

📢 Pediatricians and pediatric care teams: The American Academy of Pediatrics (AAP) now recommends genome and exome sequencing as a first-line tests. But what does that really mean in practice? Join us LIVE on LinkedIn for a conversation that breaks it down: First-Line Genomic Testing: What New AAP Guidance Means for Pediatricians Featuring Dr. Samantha Vergano, MD, FACMG, FAAP (Seattle Children's) Moderated by Abigail Sassaman, MS, CGC (GeneDx) 🗓️ Wednesday, August 20 🕐 12:15pm PT | 3:15pm ET 📍Streaming live on LinkedIn | RSVP to be reminded when we go live #Pediatrics #Genomics #GeneticTesting

Exome and genome sequencing are now recommended as first-line tests in the latest AAP guidance, but what does that mean for real-world clinical practice? Join GeneDx’s Medical Science Liaison, Abigail Sassaman, MS, CGC, and Dr. Samantha Vergano, MD, FACMG, FAAP, Associate Medical Director, Outpatient Services - Genetic Medicine at Seattle Children's, for a live conversation on how these recommendations impact pediatric care. From implementation tips to clinical workflows, we’ll break down what’s changed, what to do next, and how to navigate this shift with confidence. Bring your questions: we’ll be taking them live! 📍Streaming live on LinkedIn | RSVP to be reminded when we go live

Open a parent’s phone during the diagnostic odyssey and you won’t find a neat and tidy to-do list. You’ll find scribbled half-thoughts and spur of the moment reminders like: “Call Dr. Kim. Still no answers.” “Ask FB group about EDS.” “Google genetic testing—GeneDx?” “Another maybe. Another no.” “Don’t give up.” “Hope.” It’s not organized. It’s not linear. It’s just...everything. Questions, symptoms, follow-ups, and fears typed out as they come. Because when you’re trying to figure out what’s going on with your child, EVERYTHING matters. And then one day, finally: a diagnosis. It doesn’t solve everything, but it gives you language. A plan. A place to start.

If only people paid this much attention to their genes. For families facing rare conditions, that’s where answers often begin. While the internet debates advertising and celebrity, many parents are navigating a maze of questions, symptoms, and uncertainty. Genetics don’t just start conversations—they can change lives. Let’s make their search for answers just as impossible to ignore. #DiagnosisIsPower #Advertising #AmericanEagle

If only people paid this much attention to their genes. For families facing rare conditions, that’s where answers often begin. While the internet debates advertising and celebrity, many parents are navigating a maze of questions, symptoms, and uncertainty. Genetics don’t just start conversations—they can change lives. Let’s make their search for answers just as impossible to ignore. #DiagnosisIsPower #Advertising #AmericanEagle

5 or more years. That’s how long it takes most families to get a rare disease diagnosis. CEO Katherine Stueland is leading our mission to change that. This morning on CNBC's Squawk Box, Katherine breaks down how earlier access to genomic testing can give families and clinicians faster answers and more options. Watch the clip → https://genedx.co/3H7z7c6

The American Academy of Pediatrics (AAP) now recommends exome or genome sequencing as first-tier testing for patients with global developmental delay and intellectual disability (GDD/ID) when a specific diagnosis isn’t suspected. Here’s what this could mean for your practice: ✅ Reduces time to diagnosis ✅ Enables more targeted and timely interventions ✅ Informs care plans with greater precision ✅ Minimizes unnecessary or redundant testing This shift empowers providers to move from uncertainty to clarity, so families get the answers they need, sooner. Need support navigating testing or interpretation? We're here to help. Read more ➡️ https://lnkd.in/gBkZmBt2

Our CFO Kevin Feeley said it best: we had a strong Q2, but here’s what that impact actually looks like in the world: • Faster diagnoses • Clearer care decisions • More families getting answers that change lives As exome and genome become first-tier tests, we’re not just sharing results: we’re shaping the future. Driving education. Fueling adoption. Transforming what care looks like. Full earnings release → https://genedx.co/4fahTqZ

We’re not just growing our team — we’re growing our impact. 💙 Every role at GeneDx plays a part in delivering answers, accelerating care, and supporting families on the diagnostic journey. Sound like something you want to get behind? We’re hiring across departments. Here are some roles we're hiring for. For a full list, check out https://genedx.co/4lR67o7 #Hiring #LifeAtGeneDx